Navigation Links
3SBio Inc. Announces Unaudited Fourth Quarter and Full Year 2009 Results
Date:2/11/2010

Non-GAAP net income per ADS on a fully-diluted basis for the fourth quarter of 2009 increased to RMB0.66 (US$0.10) from RMB0.52 (US$0.08) for the same period in 2008. Non-GAAP net margin for the fourth quarter of 2009 was 19.5% as compared to 18.8% for the same period in 2008.

GAAP net income was RMB13.7 million (US$2.0 million) for the fourth quarter of 2009, an increase of RMB15.1 million over a net loss of RMB1.5 million (US$0.2 million) for the same period in 2008. GAAP net income per ADS on a fully-diluted basis for the fourth quarter of 2009 increased to RMB0.63 (US$0.09) from a loss of RMB0.07 (US$0.01) for the same period in 2008. GAAP net margin for the fourth quarter of 2009 was 18.4% as compared to -2.4% for the same period in 2008.

2010 Full Year Guidance and Selected Company Objectives

Based on current market and operating conditions and the following goals, the Company's total net revenue target for the full year 2010 is between US$56 million to US$58 million, an estimated year-over-year increase of approximately 20% to 25%. Other operating objectives include:

    -- Initiate Feraheme registration trial in China, pending SFDA approval.
    -- Continue to work with the SFDA to secure regulatory approval of the
       three new product programs: 36,000 IU dosage formulation of EPIAO,
       Nuleusin and TPIAO label extension for the treatment of ITP.
    -- Complete validation of the new plant and obtain GMP certification from
       the SFDA.
    -- Explore global biosimilar 
'/>"/>
SOURCE 3SBio Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26

Related biology technology :

1. 3SBio Inc. to Present at the UBS Global Life Sciences Conference
2. 3SBio Inc. to Hold Annual General Meeting
3. 3SBio Inc. Schedules 2007 Third Quarter Earnings Release On Tuesday, November 13, 2007
4. 3SBio Inc. To Present at the 19th Annual Piper Jaffray Health Care Conference
5. 3SBio Inc. Announces Appointment of Kevin Sow Peng Teo as Chief Financial Officer
6. 3SBio Inc. to Present at the Merrill Lynch Global Pharmaceutical, Biotechnology and Medical Device Conference
7. 3SBio Inc. Schedules 2007 Fourth Quarter and Full Year Earnings Release on Wednesday, February 20, 2008
8. 3SBio Inc. Announces Change to the Board of Directors
9. 3SBio Inc. Announces Unaudited Fourth Quarter and Fiscal Year 2007 Results
10. 3SBio Inc. Announces Promotion of David Chen as Chief Operating Officer
11. 3SBio Inc. Approves Share Repurchase Program
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/26/2014)... 26, 2014   Lycera Corp ., a ... medicines to treat autoimmune disease and cancer based ... the appointment of Harinder Singh , Ph.D., ... Dr. Singh will lead the board,s efforts to ... ongoing research programs and pipeline of therapies targeting ...
(Date:8/26/2014)... Genedata, a leading provider of ... science research, today announced the Genedata Screener® ... in Asia, Europe, and North America during September ... leading research organizations will gather for annual User ... and upcoming challenges in all areas of screening. ...
(Date:8/26/2014)... , Aug. 26, 2014  That,s Nice LLC, a ... today announced the formation of a new dedicated team ... The expanded team will combine current and new staff ... That,s Nice. Guy Tiene ... lead the team. Tiene was previously Director of Marketing ...
(Date:8/26/2014)... Formedix, the leading provider of clinical ... Transform for MARVIN: the latest addition to its ... line. It was developed in collaboration with Formedix ... the EDC and Clinical Data Management system. , ... allowing instantaneous visualization of MARVIN eCRFs as they ...
Breaking Biology Technology:Lycera Appoints Harinder Singh, Ph.D., as Chair of Scientific Advisory Board 2Lycera Appoints Harinder Singh, Ph.D., as Chair of Scientific Advisory Board 3Thought Leaders to Explore Innovations in SPR & Combination Screening at Genedata Screener User Group Meetings 2Thought Leaders to Explore Innovations in SPR & Combination Screening at Genedata Screener User Group Meetings 3That's Nice Announces Expanded Offering For Strategic Content And Public Relations 2That's Nice Announces Expanded Offering For Strategic Content And Public Relations 3Introducing Transform for MARVIN: Providing Further Flexibility for CROs and Sponsors in Partnership with XClinical 2
... of Panzem(R) NCD and Avastin(R) May Slow ... EntreMed, Inc.,(Nasdaq: ENMD ), a ... of cancer and inflammatory diseases, today,announced the ... 2 multi-center,study combining Panzem(R) NCD with Avastin(R) ...
... YORK, Jan. 28 The Medefield Group, the ... market research, consulting,and communications companies, is pleased to ... After another year of unprecedented growth,attributed to Medefield,s ... client base, the company is adding to its,ever-growing ...
... (Nasdaq: MNKD ), focused on discovering, developing and,commercializing ... present at the Wachovia Healthcare Conference on January 30, ... Boston, MA., Interested parties can access a link ... Investor Relations section of the Company,s website at, http://www.mannkindcorp.com ...
Cached Biology Technology:EntreMed Presents Interim Results for Phase 2 Carcinoid Tumor Study 2EntreMed Presents Interim Results for Phase 2 Carcinoid Tumor Study 3EntreMed Presents Interim Results for Phase 2 Carcinoid Tumor Study 4Medefield Announces New Appointments to North American Business Unit 2
(Date:8/26/2014)... tent over a colony of harmful bacteria, biofilms ... Microorganisms protected in a biofilm pose a significant ... recalcitrance to treatment, and biofilm-protected bacteria account for ... humans and are 50 to 1,000 times more ... "In essence, we may have stumbled onto a ...
(Date:8/26/2014)... obtaining an unprecedented view of a type of ... of neurological illnesses, including Alzheimer,s disease, Parkinson,s disease, ... stroke. , The team of biologists at Cold ... Energy,s Advanced Photon Source at Argonne National Laboratory ... NMDA (N-methyl, D-aspartate) receptor should serve as template ...
(Date:8/26/2014)... New Zealand endemic tree has for the last 31 years ... Australian shrubs and small trees. A New Zealand botanist has ... astonishing cryptic diversity behind what was long considered a single ... journal PhytoKeys . , Known to botanists ... the many discoveries made in the north-western South Island of ...
Breaking Biology News(10 mins):Breakthrough antibacterial approach could resolve serious skin infections 2Breakthrough antibacterial approach could resolve serious skin infections 3Unprecedented detail of intact neuronal receptor offers blueprint for drug developers 2Unprecedented detail of intact neuronal receptor offers blueprint for drug developers 3And then there were 10 -- unexpected diversity in New Zealand kanuka genus Kunzea 2And then there were 10 -- unexpected diversity in New Zealand kanuka genus Kunzea 3
... than 10 percent each year from 2010 to 2050 ... fuels, but this is an unsustainable prospect. According to ... Governance, Economy and Ecology such a large growth rate ... otherwise each new power plant will simply cannibalize the ...
... (March 4, 2008) A unique dietary supplement called ... following experimental stroke. A nutritional supplement product, NutraStem also ... blueberry, green tea, vitamin D3 and carnosine extracts- a ... protecting against brain damage. Stroke is the third ...
... Research Council (BBSRC) funded scientists at the University of ... process of carbon dioxide fixation in plants. ... Proceedings of the National Academy of Sciences, increases our ... crop improvement and fourth generation biofuels. The mechanism, which ...
Cached Biology News:Nuclear cannibals 2Blueberry and green tea containing supplement protects against stroke damage 2Scientists uncover a novel mechanism that regulates carbon dioxide fixation in plants 2
... universal digital valve, just 8 mm in width. ... features in a single glass-reinforced, PBT (Polybutylene Terephthalate) ... in width. , Meets a range of pressure ... , Satisfies a 0.016 sccm leakage specification (0.2 ...
... The FilterMate is a compact, versatile system ... a 96- or 24-well microplates into a ... microplate liquid scintillation and gamma counter. The ... samples for applications such as cell proliferation, ...
... General description: Designed for use with ... CLS number is a new product number, ... If showing no availability yet, please order ... contact customer service for assistance. Comp Dim: ...
... G bind specifically to Fc regions of ... G conjugates are commonly used as affinity ... subtypes from serum, hybridoma ascites fluids, tissue ... reagents are also commonly used to capture ...
Biology Products: